Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
1,268
1,268 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- OnvansertibPhase 22 trials
Cardiff Oncology · Metastatic Colorectal Cancer, CRC, KRAS/NRAS Mutation
- PD-L1 monoclonal antibodyPhase 22 trials
Suzhou BlueHorse Therapeutics Co., Ltd. · Non-Small Cell Lung Cancer, Advanced Malignant Solid Tumor
- Personalized Neoantigen Peptide VaccinePhase 22 trials
Seqker Biosciences, Inc. · Solid Tumors, Advanced Cancer, Recurrent Cancer
- PF-07104091ovarian, SCLCPhase 22 trials
Pfizer · Breast Cancer, Solid Tumors, Small Cell Lung Cancer
- PM54Phase 22 trials
PharmaMar · Advanced Solid Tumor, Advanced Malignancies
- QHL-1618ALK-N001Phase 22 trials
Zhejiang Anglikang Pharmaceutical Co., Ltd. · Advanced Gastrointestinal Tumors, Advanced Solid Tumors
- QLC1401Phase 22 trials
Qilu Pharmaceutical Co., Ltd. · Advanced Breast Cancer, Advanced ER+/HER2- Breast Cancer
- QLH12016Phase 22 trials
Qilu Pharmaceutical Co., Ltd. · Prostatic Neoplasms, Advanced Prostate Cancer
- quaratusugene ozeplasmidREQORSAPhase 22 trials
Genprex, Inc. · Carcinoma, Non-Small Cell Lung, Small Cell Lung Cancer Extensive Stage
- QuavonlimabMK-1308Phase 22 trials
Merck & Co. · Melanoma, Advanced Non-Small Cell Lung Cancer
- RadspherinPhase 22 trials
Oncoinvent Solutions AS · Peritoneal Carcinomatosis, Ovarian Cancer, Peritoneal Carcinoma
- RAPA-201 Rapamycin Resistant T CellsRAPA-201 cellsPhase 22 trials
Rapa Therapeutics LLC · Malignant Melanoma, Malignant Melanoma With Metastasis, Malignant Melanoma Stage IIIc
- RBS2418Phase 22 trials
Riboscience, LLC. · Metastatic Colorectal Cancer, Advanced Colorectal Cancer, Advanced Unresectable Hepatocellular Carcinoma
- RC108Phase 22 trials
RemeGen Co., Ltd. · Non-Small Cell Lung Cancer, Digestive Cancer
- RDEABSK141-Recommended Expansion, S095018 RecommendedPhase 22 trials
Abbisko Therapeutics Co, Ltd · Solid Tumors, Adult, Non-small Cell Lung Cancer (NSCLC)
- REGN4336Phase 22 trials
Regeneron · Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)
- rhuGM-CSFGranulocyte-Macrophage Colony-Stimulating FactorPhase 22 trials
Aston Sci. Inc. · Gastric Cancer, Advanced Ovarian Cancer
- S095029Phase 22 trials
Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC), MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer
- SapanisertibFTH-003, MLN0128Phase 22 trials
Faeth Therapeutics · Endometrial Cancer, HR+ HER2- Breast Cancer
- SAR445877Phase 22 trials
Sanofi · Solid Tumor, Gastric Cancer, Oesophageal Carcinoma
- SCTB39-1Phase 22 trials
Sinocelltech Ltd. · Advanced Malignant Solid Tumor
- SCTB39GPhase 22 trials
Sinocelltech Ltd. · Advanced Malignant Solid Tumor, Advanced Malignant Solid Tumors
- SelicrelumabPhase 22 trials
Roche (Genentech) · Metastatic Breast Cancer, Pancreatic Adenocarcinoma
- SerabelisibFTH-001, MLN1117Phase 22 trials
Faeth Therapeutics · Endometrial Cancer, HR+ HER2- Breast Cancer
- SHR-4375Phase 22 trials
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced Solid Tumor, Solid Tumors
- SHR-4849Phase 22 trials
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Malignant Solid Tumors
- silevertinibBDTX-1535Phase 22 trials
Black Diamond Therapeutics, Inc. · Glioblastoma (GBM), Newly Diagnosed Glioblastoma, GBM
- SKB103Phase 22 trials
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Advanced Solid Tumors, Breast Cancer
- SKB500Phase 22 trials
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Esophageal Squamous Cell Carcinoma, Small Cell Lung Cancer
- SKB518Phase 22 trials
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Advanced Gynecological Malignancies, Lung Carcinoma
- SPGL008Phase 22 trials
Shenyang Sunshine Pharmaceutical Co., LTD. · NMIBC, Non Small Cell Lung Cancer
- SSGJ-612HER2-targeted antibodyPhase 22 trials
Shenyang Sunshine Pharmaceutical Co., LTD. · Locally Advanced (Unresectable) or Metastatic Solid Tumors, Metastatic Breast Cancer
- SSGJ-705Phase 22 trials
Shenyang Sunshine Pharmaceutical Co., LTD. · Locally Advanced, Recurrent or Metastatic Malignancies, Locally Advanced (Unresectable) or Metastatic Solid Tumors
- STAR0602InvikafuspPhase 22 trials
Marengo Therapeutics, Inc. · Triple Negative Locally Advanced Non-resectable Breast Cancer, HR+, HER2-, Advanced Breast Cancer, Advanced Solid Tumors
- Sutetinib MaleatePhase 22 trials
Teligene US · Non-small Cell Lung Cancer
- SYH2051Phase 22 trials
CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors, Breast Cancer
- SYS6041Phase 22 trials
CSPC Megalith Biopharmaceutical Co.,Ltd. · Ovarian Cancer, Recurrent Ovarian Cancer, Advanced Solid Tumors
- TCC1727Phase 22 trials
Beijing Tide Pharmaceutical Co., Ltd · Patients with Advanced Solid Tumors, Solid Cancers, NSCLC (Advanced Non-small Cell Lung Cancer)
- Tigilanol TiglateEBC-46Phase 22 trials
QBiotics Group Limited · Soft Tissue Sarcoma, Head and Neck Cancer
- TNO155Phase 22 trials
Novartis · Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer, Advanced Solid Tumors Harboring the KRAS G12C Mutation, KRAS G12C Mutant Solid Tumors
- TQB2916Phase 22 trials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Soft Tissue Sarcoma, Melanoma, Pancreatic Cancer
- TQB6411Phase 22 trials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Advanced Lung Cancer, Esophageal Cancer
- TRK-950Phase 22 trials
Toray Industries, Inc · Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
- TST001Phase 22 trials
Transcenta Therapeutics (Hangzhou) Co., Ltd. · Advanced Cancer, Gastric Cancer, Gastroesophageal-junction Cancer
- TTI-101Phase 22 trials
Tvardi Therapeutics, Incorporated · Hepatocellular Carcinoma, Idiopathic Pulmonary Fibrosis
- TU2218Phase 22 trials
TiumBio Co., Ltd. · Advanced Solid Tumor, Solid Tumor, Biliary Tract Cancer
- TYK-00540Phase 22 trials
TYK Medicines, Inc · mCRPC, HR-positive, HER2-negative Advanced Breast Cancer
- VEGF antibodyPhase 22 trials
Lepu Biopharma Co., Ltd. · Hepatocellular Carcinoma, Advanced Colorectal Cancer
- VG2025Phase 22 trials
Virogin Biotech Ltd. · Intrahepatic Cholangiocarcinoma, Colorectal Cancer With Hepatic Metastases
- VortosiranPhase 22 trials
Ribocure Pharmaceuticals AB · Venous Thromboembolism (VTE), Cancer, Pulmonary Embolism (Diagnosis)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.